Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
R. Bonassi Machado, L. de Melo Pompei, E. A. P. Nahas, J. Nahas-Neto, L. da Costa-Paiva, S. Y. O. Del Debbio, M. Badalotti, M. C. O. Wender & A. M. Cruz. (2023) Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women. Climacteric 26:4, pages 401-407.
Read now
Read now
L-å. Mattsson, H. e. Ipsen, C-j. Granqvist & M. Kokot-Kierepa. (2015) Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy. Climacteric 18:3, pages 419-425.
Read now
Read now
P. Stute, H.-G. Becker, J. Bitzer, D. Chatsiproios, F. Luzuy, M. von Wolff, D. Wunder & M. Birkhäuser. (2015) Ultra-low dose – new approaches in menopausal hormone therapy. Climacteric 18:2, pages 182-186.
Read now
Read now
. (2014) Abstracts of Posters. Climacteric 17:sup1, pages 48-108.
Read now
Read now
D. W. Sturdee. (2013) Are progestins really necessary as part of a combined HRT regimen?. Climacteric 16:sup1, pages 79-84.
Read now
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Read now
D. W. Sturdee & A. Pines. (2011) Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 14:3, pages 302-320.
Read now
Read now
G. Samsioe & J. Hruska. (2010) Optimal tolerability of ultra-low-dose continuous combined 17β-estradiol and norethisterone acetate: laboratory and safety results. Climacteric 13:1, pages 34-44.
Read now
Read now
Nathan W Kopper, Jennifer Gudeman & Daniel J Thompson. (2008) Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologies. Drug Design, Development and Therapy 2, pages 193-202.
Read now
Read now
Nick Panay & Anna Fenton. (2008) HRT: does the dose matter?. Climacteric 11:3, pages 177-178.
Read now
Read now
M. H. Birkhäuser, M. H. Birkhäuser, N. Panay, D. F. Archer, D. Barlow, H. Burger, M. Gambacciani, S. Goldstein, J. A. Pinkerton & D. W. Sturdee. (2008) Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 11:2, pages 108-123.
Read now
Read now
Articles from other publishers (11)
Petra Stute, Linus Josef Walker, Astrid Eicher, Elena Pavicic, Argyrios Kolokythas, Susanne Theis, Marc von Gernler, Michael von Wolff & Sabrina Vollrath. (2023) Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review. Best Practice & Research Clinical Endocrinology & Metabolism, pages 101815.
Crossref
Crossref
Lucia Costa-Paiva, Maria Celeste O Wender, Rogerio B Machado, Luciano M Pompei, Eliana A Nahas, Jorge Nahas-Neto, Sonia Y Del Debbio, Mariangela Badalotti & Achilles M Cruz. (2022) Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: A randomized, placebo-controlled, double-blind trial. Post Reproductive Health 28:3, pages 149-157.
Crossref
Crossref
Young Mee Lee & Hwi-yeol Yun. (2017) Hormone Therapy Review for Perimenopausal Symptoms: Focused on Perimenopausal Women without Other Risk Factors. Korean Journal of Clinical Pharmacy 27:4, pages 199-206.
Crossref
Crossref
Susan Furness, Helen Roberts, Jane Marjoribanks & Anne Lethaby. (2012) Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Nick Panay. 2012. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
553
564
.
David F. Archer. (2011) Delivery of therapeutic agents to the target tissue. Menopause 18:10, pages 1040-1041.
Crossref
Crossref
I. Wiegratz. (2011) Ultraniedrig dosierte HormonersatztherapieUltralow-dose hormone replacement therapy. Gynäkologische Endokrinologie 9:3, pages 165-170.
Crossref
Crossref
David F. Archer. (2011) Endometrial bleeding in postmenopausal women. Menopause 18:4, pages 416-423.
Crossref
Crossref
David F. Archer. (2010) Tissue-Selective Estrogen Complexes. Drugs & Aging 27:7, pages 533-544.
Crossref
Crossref
Jo Marsden & David Sturdee. (2009) Cancer issues. Best Practice & Research Clinical Obstetrics & Gynaecology 23:1, pages 87-107.
Crossref
Crossref
Odd Erik Johansen & Erik Qvigstad. (2008) Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in Therapy 25:6, pages 525-551.
Crossref
Crossref